Cargando…
Interfering cellular lactate homeostasis overcomes Taxol resistance of breast cancer cells through the microRNA-124-mediated lactate transporter (MCT1) inhibition
BACKGROUND: Breast cancer, the most common invasive cancer of women, is a malignant neoplasm and the second main cause of cancer death. Resistance to paclitaxel (Taxol), one of the frequently used chemotherapy agents for breast cancer, presents a major clinical challenge. Recent studies revealed tha...
Autores principales: | Hou, Lu, Zhao, Yi, Song, Guo-qing, Ma, Ying-han, Jin, Xiao-hu, Jin, Si-li, Fang, Yi-han, Chen, Yi-chong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657142/ https://www.ncbi.nlm.nih.gov/pubmed/31367191 http://dx.doi.org/10.1186/s12935-019-0904-0 |
Ejemplares similares
-
Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
por: Dell’Anno, Irene, et al.
Publicado: (2020) -
Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis
por: Sonveaux, Pierre, et al.
Publicado: (2012) -
Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells
por: Benjamin, Don, et al.
Publicado: (2018) -
Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
por: Zhou, Ming, et al.
Publicado: (2010) -
Catalytically inactive carbonic anhydrase‐related proteins enhance transport of lactate by MCT1
por: Aspatwar, Ashok, et al.
Publicado: (2019)